Belizatinib/ceritinib/crizotinibDevelopement of multi-drug resistance in non small cell lung cancer: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1658卷 / 1期
关键词：
D O I：
10.1007/s40278-017-32278-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：81 / 81
相关论文
共 50 条
  • [21] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2019, 1754 (1) : 120 - 120
  • [22] AfatinibAfatinib resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2017, 1656 (1) : 21 - 21
  • [23] CrizotinibAcquired resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2014, 1500 (1) : 15 - 15
  • [24] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2017, 1633 (1) : 231 - 231
  • [25] The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non-Small Cell Lung Cancer
    Friboulet, Luc
    Li, Nanxin
    Katayama, Ryohei
    Lee, Christian C.
    Gainor, Justin F.
    Crystal, Adam S.
    Michellys, Pierre-Yves
    Awad, Mark M.
    Yanagitani, Noriko
    Kim, Sungjoon
    Pferdekamper, AnneMarie C.
    Li, Jie
    Kasibhatla, Shailaja
    Sun, Frank
    Sun, Xiuying
    Hua, Su
    McNamara, Peter
    Mahmood, Sidra
    Lockerman, Elizabeth L.
    Fujita, Naoya
    Nishio, Makoto
    Harris, Jennifer L.
    Shaw, Alice T.
    Engelman, Jeffrey A.
    CANCER DISCOVERY, 2014, 4 (06) : 662 - 673
  • [26] GefitinibGefitinib resistance and transformation from non-small cell lung cancer to small cell lung cancer: case report
    Reactions Weekly, 2015, 1580 (1) : 186 - 186
  • [27] Ceritinib/crizotinibDevelopment of drug resistance: case report
    Reactions Weekly, 2017, 1633 (1) : 178 - 178
  • [28] Gefitinib/osimertinibAcquired drug resistance and transformation to small cell lung cancer: case report
    Reactions Weekly, 2020, 1804 (1) : 134 - 134
  • [29] Drug resistance in non-small cell lung cancer
    Monzo, M
    Rosell, R
    Taron, M
    LUNG CANCER, 2001, 34 : S91 - S94
  • [30] Multi-drug resistance and cancer
    Atalay, Can
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (05) : 511 - 520
12345